GoHealth’s (GOCO) “Market Perform” Rating Reiterated at William Blair

William Blair reissued their market perform rating on shares of GoHealth (NASDAQ:GOCO) in a research note released on Wednesday, Marketbeat.com reports. William Blair also issued estimates for GoHealth’s Q4 2025 earnings at ($2.03) EPS, FY2025 earnings at ($4.89) EPS and FY2026 earnings at ($8.28) EPS.

Other equities research analysts have also issued research reports about the company. Royal Bank Of Canada reduced their price target on GoHealth from $18.00 to $12.00 and set a “sector perform” rating on the stock in a research report on Thursday, August 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of GoHealth in a research report on Wednesday, November 5th. Finally, Noble Financial reissued an “outperform” rating on shares of GoHealth in a report on Friday, August 8th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $12.00.

GoHealth Price Performance

Shares of GoHealth stock opened at $2.57 on Wednesday. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.64 and a quick ratio of 1.56. GoHealth has a 12 month low of $2.17 and a 12 month high of $21.00. The stock has a market capitalization of $73.78 million, a P/E ratio of -0.16 and a beta of 1.57. The business has a 50 day simple moving average of $4.08 and a two-hundred day simple moving average of $5.27.

GoHealth (NASDAQ:GOCO) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.06) by $1.87. The company had revenue of $34.19 million during the quarter, compared to analysts’ expectations of $102.36 million. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. As a group, analysts predict that GoHealth will post -5.5 EPS for the current fiscal year.

Institutional Investors Weigh In On GoHealth

Hedge funds have recently modified their holdings of the stock. Public Sector Pension Investment Board acquired a new position in GoHealth during the third quarter valued at approximately $8,100,000. Redwood Capital Management LLC bought a new stake in shares of GoHealth in the 3rd quarter valued at approximately $4,455,000. 4D Advisors LLC bought a new stake in GoHealth during the first quarter valued at $1,840,000. Corient Private Wealth LLC grew its holdings in shares of GoHealth by 7.7% during the second quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock valued at $699,000 after purchasing an additional 8,979 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of GoHealth by 4.3% in the 2nd quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after purchasing an additional 4,955 shares during the last quarter. 24.21% of the stock is owned by institutional investors and hedge funds.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.